Not a member? Register now and gain FREE access to over 100 private,
pre-IPO, IPO and Small Cap ASX Listed opportunities!

Wholesale Investor is a FREE service for high net worth, professional and international investors. Registration takes less than 30 second and gives you:

Email Or Login with your Please wait...

Archive: Healthcare / Life Sciences / Medical Devices

arthritis 75x55

Arthritis Relief Plus Annual Update 2016; US FDA Compliance Completed, Australian Government Support & First Commercial Batch in US

Arthritis Relief Plus Ltd (ARP) attained countless achievements during 2016. The company managed to complete US FDA compliance, securing an OTC topical drug status/ classification for 4Jointz. With also securing Australian Government support in the first cohort at the Rocketspace … Continue reading

Aurthor_80x80

Author-It Annual Update 2016; NZ$10M Raised & Platform Expansion

Author-it, the leading content management software company serving the Life Sciences industry indicated another successful year. In August 2016, the Company completed a Series C funding totaling $10m NZ. The company successfully signed and added a series of Global 50 … Continue reading

Proteo-logo-HR-80x80

Proteomics International Raises $1.44 Placement and Now Offering a Share Purchase Plan

2nd December 2016, ASX Announcement Proteomics International is a specialist innovation-driven medical technology company based in Perth, Western Australia. Focused on the area of proteomics- the industrial scale study of the structure and functions of proteins. Established in 2001, providing services … Continue reading

TFS

TFS Executes 10 Year Contract with WA Forest Products Commission

19th December 2016 – ASX Release TFS Corporation Ltd (ASX: TFC), the world’s largest owner and manager of commercial Indian sandalwood plantations, today announced the execution of a ten-year contract with the West Australian Forest Products Commission for the supply … Continue reading

Proteo-logo-HR-80x80

Proteomics International (ASX: PIQ) Diabetic Kidney Disease Test Granted Patent in Russia

19th December 2016 – ASX Announcement Medtech company Proteomics International Laboratories (PILL) has been granted a patent in the Russian Federation for the company’s breakthrough diagnostic and prognostic test for diabetic kidney disease, “PromarkerD”. By country, the Russian Federation has … Continue reading

PILL logo HR

PromarkerD Shows Improved Predictive Ability & Robustness

Proteomics International Laboratories Ltd (ASX: PIQ) is pleased to provide an update on its clinical studies for PromarkerD, the company’s breakthrough test for the prediction of diabetic kidney disease. Highlights: PromarkerD predicts diabetic kidney disease across all major clinical definitions … Continue reading

Alcidion Logo (2)

Alcidion Executive Director Interview With FNN

15th December 2016 – ASX Announcement Alcidion Group Ltd (ASX: ALC) Executive Director, Nathan Buzza, presented an update to shareholders on the medical technology market, the benefits that hospitals and healthcare providers can expect from the company’s products and the … Continue reading

Slide110

TFS Corporation Limited (ASX:TFC)

TFS Corporation is the world’s largest owner and manager of Sandalwood Album plantations, grown in Northern Australia. Continue reading

Alcidion Logo (2)

Coffs Harbour Health Campus Launches Alcidion’s iCVIS

13 December 2016 – ASX Announcement Highlights: Coffs Harbour Health Campus launches Intelligent Cardiovascular Information System (iCVIS). First installation of iCVIS in NSW. Successful integration with state-wide Cerner Patient Administration System (PAS). Strengthening of the commercialisation of iCVIS through FUJIFILM. … Continue reading

medad

MedAdvisor – Rapid Growth of Patient Engagement Programs

12th December 2016 – ASX Announcement  Rapid growth of Patient Engagement Programs (PEPs), now with 18 medications part of educational programs, up from 8 medications 12 months ago PEPs reaching over 55,000 patients, delivering value to both manufacturers, pharmacies and … Continue reading

medad

MedAdvisor Signs Pfizer for Patient Engagement Program

8th December 2016 – ASX Announcement  MedAdvisor signs Pfizer, the world’s largest research-based pharmaceutical company to deliver a patient engagement program (PEP) on its platform Pfizer will use the MedAdvisor platform to deliver information and advice to patients to enhance … Continue reading

PILL logo HR

Proteomics Share Purchase Plan Offer Document

7th December 2016 – ASX Announcement  Proteomics International Laboratories Ltd (ASX:PIQ) (the Company, PILL) is pleased to present to you the opportunity to apply to increase your investment in the Company through an offer of shares under the Company’s Share … Continue reading

QBiotics-logo-mono-blue-strapline-80x802 (1)

QBiotics Featured on Channel 9 Today Show

6th december 2016, 9Now A potential cancer cure has been discovered right here in Australia’s rainforests, and Dr Victoria Gordon the CEO of Q-Biotics has all the details. To view the video on 9Now, please click on the button below.

4dx-80x80

Australia’s 4Dx Making Waves In Respiratory Healthcare

2nd December 2016 Australian medtech startup 4Dx is making a bold foray into the global respiratory diagnostics marketplace after strong support from the U.S, U.K and Australian investment community.  Their $4M Series A investment round is set to close, oversubscribed, … Continue reading

PILL logo HR

Proteomics Completes $1.44 million Placement and Offers SPP

2nd December 2016, ASX Announcement Medtech company Proteomics International Laboratories Ltd (PILL, ASX: PIQ) is pleased to announce it has completed the first phase of a targeted capital raising by placement of 6m shares at $0.24 to raise $1.44m (the … Continue reading

alcidion

Alcidion Chairman’s Letter 2016, Presentation & Appointment of Secretary

29th November 2016, ASX Announcement Alcidion Group Limited (Alcidion or Company) is pleased to present its Annual Report for the financial year ended 30 June 2016 (FY16 or Period). Alcidion is focussed on anticipating the needs of the health care … Continue reading

medad

MedAdvisor Partners with Asthma Australia

29th November 2016, ASX Announcement  MedAdvisor partners with Asthma Australia, Australia’s peak body supporting people with asthma and their carers Partnership aims to improve health outcomes for the estimated 2.4 million (1 in 10) Australians living with asthma, via the … Continue reading

4dx-80x80

Prominent Oncologist & Researcher Joins 4Dx Board

November 30, 2016 Australian technology start-up 4DX has attracted one of the biggest names in global oncology as its latest Board member. Robert A. Figlin, MD, FACP, joins the 4Dx board on December 1st.  Dr Figlin is Deputy Director of … Continue reading

alcidion

Alcidion to Present at ASX CEO Sessions

28th November 2016, ASX Announcement Alcidion Group Limited (ASX:ALC) today announced that it has accepted an invitation to present at The CEO Sessions on Tuesday, 6th December 2016. The CEO Sessions, presented by the Australian Securities Exchange (ASX) and the … Continue reading

Antisense-Logo-email

Antisense Therapeutics Ltd (ASX: ANP)

Antisense Therapeutics Ltd (ASX: ANP) is an Australian publicly traded biopharmaceutical development company. Continue reading

analytica80x80

Analytica Chairman’s Address, Annual General Meeting & Presentation

24th November 2016, ASX Announcement Over the last 12 months the Analytica team has worked tirelessly to put us closer to a position to enable execution of a global licence deal for both the PeriCoach and the ASB. As stated … Continue reading

alcidion

Alcidion to Present at Wilsons Healthcare IT Conference

15th November 2016, ASX announcement Alcidion Group Limited (ASX:ALC) today announced that it will present at the Wilsons Healthcare IT Conference on Wednesday, 30th November 2016. The goal of the conference is to educate investors about how technology can increase … Continue reading

4dx-80x80

4Dx to Close Capital Raise

4Dx Limited is pleased to announce that due to an overwhelming response, as of 5pm AEDT, Friday, 9 December, 2016, the Company’s $4m Series A capital round will be officially closed.  It is anticipated that the round will close oversubscribed. 4Dx is … Continue reading

4dx-80x80

‘Next Cochlear’ 4Dx Closes Capital Raise as FDA Approval Enters Sight

21st November 2016, AFR Yolanda Redrup Medical imaging startup 4Dx has raised $2.5 million from a range of retail and high net worth investors, which the business will invest in its clinical trials that will see the company approved by the … Continue reading

alcidion

Alcidion TechKnow Investor Roadshow Interview

17th November 2016, ASX Announcement Alcidion Group Limited (ASX:ALC) today announced that Executive Director, Mr. Nathan Buzza’s interview from the TechKnow Invest Roadshow is available on the Alcidion website. Mr. Buzza provides a comprehensive overview of Alcidion as an investment … Continue reading

suda80x80

SUDA Presents Data On Novel Penetration-Enhancing Technology

17th November 2016 SUDA LTD (ASX: SUD), a leader in oro-mucosal drug delivery, today announced that Mr. Stephen Carter, Managing Director and CEO, presented data on the Company’s novel penetration-enhancing technology at the Annual Symposium of Drug Delivery Systems, being … Continue reading

Proteo-logo-HR-80x80

Proteomics and Linear Partner in Testing and Clinical Trials

15th November 2016, ASX Announcement Medical technology company Proteomics International Laboratories Ltd (ASX: PIQ) (PILL) and clinical trial specialists Linear Clinical Research Ltd (Linear) are set to offer a combined advanced analytical testing and clinical trial package from January 2017. … Continue reading

Proteo-logo-HR-80x80

Proteomics PromarkerD Test Kit Production Deal Signed

11th November 2016, ASX Announcement Medtech company Proteomics International Laboratories Ltd (PILL, ASX: PIQ) today reached a strategic milestone in its commercialisation pathway for PromarkerD, the company’s predictive test for diabetic kidney disease. PILL signs production contract with Monash Antibody … Continue reading

4dx-80x80

4Dx Features In The Australian

14th November 2016, The Australian By Sarah-Jayne Tasker A “dream job” studying airflow through jet engines has led to an innovative lung imaging system that Professor Andreas Fouras is convinced will disrupt a $25 billion a year global industry and … Continue reading

HCD-logo_RGB

House Call Doctor Pty Ltd

House Call Doctor is Australia’s fastest growing after hours, home visiting medical service. Continue reading

alcidion

Alcidion to Conduct WA Roadshow and Meeting with WA Minister for Health

7th November 2016, ASX Announcement Alcidion Group Limited (ASX:ALC) today announced a two-day roadshow aimed at extending relationships in Western Australia. Executive Director and CEO of Alcidion, Mr. Ray Blight will be meeting with numerous stakeholders throughout the state health … Continue reading

medad

MedAdvisor Completes Healthnotes Acquisition

31st October 2016, ASX Announcement MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication management company, is pleased to announce it has completed the acquisition of Health Enterprises 2 Pty Ltd (“Healthnotes”), a leader in healthcare technology for medication … Continue reading

Proteo-logo-HR-80x80

Proteomics Wins WA Exporter of the Year

31st October 2016, ASX Announcement Medical technology company Proteomics International Laboratories Ltd (ASX: PIQ) has edged out shipbuilding giant Austal and Fortescue Metals Group to win the WA Exporter of the Year Award. The company also took out the Health … Continue reading

medad

MedAdvisor AGM CEO Presentation

26th October 2016, ASX Announcement FY16 Results Overview Total revenue of $1.76m, representing a 24% increase on FY15 on a normalised basis – Normalised basis excludes a final license fee payment of $500,000 from FY15 revenue of $1.9 million Revenue … Continue reading

alcidion

Alcidion TechKnow Invest Roadshow Recording

26th October 2016, ASX Announcement Alcidion Group Limited (ASX:ALC) presented at the TechKnow Invest Roadshow in Melbourne, Sydney and Brisbane last week, 18 , 20 and 21 October 2016. Alcidion had a successful week at the TechKnow conference and with … Continue reading

Ondek-logo-RGB1

Ondek Pty Ltd

Ondek is an unlisted company founded by Australian Nobel Laureate to develop and commercialise novel treatments in rapidly growing international market for allergic indications. Continue reading

medad

Bupa Supports MedAdvisor with Patients Leaving Hospital

20th October 2016, ASX Announcement Highlights MedAdvisor has extended its existing relationship with Bupa into certain Healthscope Hospitals, via the “Always Events” agreement MedAdvisor platform is now being offered to Bupa patients as they are discharged from certain Healthscope Hospitals … Continue reading

Proteo-logo-HR-80x80

Proteomics Targets Gastro-Causing Parasite

20th October 2016, ASX Announcement Perth life sciences company Proteomics International Laboratories Ltd (PILL, ASX: PIQ) has successfully applied its biomarker discovery platform Promarker to the parasite Giardia. PILL maps samples from the gastro-causing parasite Giardia. Giardiasis is one of … Continue reading

medad

MedAdvisor Completes $8M Oversubscribed Capital Raising

19th October 2016, ASX Announcement Highlights MedAdvisor has successfully raised $8 million via an institutional placement (Placement) Placement was significantly oversubscribed, with strong support from both existing and new shareholders Strong participation from leading Australian institutions and pharmacies, providing further … Continue reading

Proteo-logo-HR-80x80

Proteomics Appoints New Non-Executive Director

14th October 2016, ASX Announcement Life sciences company Proteomics International Laboratories Ltd (PILL, ASX: PIQ) is delighted to announce the appointment of Mr Roger Moore as a Non-Executive Director of the Company. The appointment brings key industry and sector experience … Continue reading

medad

MedAdvisor Continues Growth of Tap To Refill Feature

12th October 2016, ASX Announcement Tap to Refill function continues to gain traction, reaching over 2 million script orders for the first time since inception in Q1, CY 2014 Annualised script value now passing through the platform is over $75 million, … Continue reading

QBiotics-logo-mono-blue-strapline (1)

QBiotics Share Offer Oversubscribed by $4.3m

Long term Axstra client QBiotics Limited has successfully raised in $16.8 million from its latest round of capital raising. The Company’s Prospectus Share Offer was oversubscribed by $4.3m following high demand from investors. In light of the interest in QBiotics, a Private … Continue reading

medad

MedAdvisor Partners with Osteoporosis Australia

6th October 2016, ASX Announcement Medadvisor partners with national not-for-profit health association Osteoporosis Australia Deal to offer medadvisor to a highly relevant patient population Partnership will boost awareness of medadvisor to patients with osteoporosis to increase convenience and medication adherence … Continue reading

alcidion

Alcidion to Present at Health Informatics New Zealand (HiNZ)

7th October 2016, ASX Announcement Alcidion Group Limited (ASX:ALC) today announced that it will present at the Health Informatics New Zealand Conference from 1-3 November 2016. In 2016 the HiNZ Conference has combined with the Global Telehealth, Successes and Failures in … Continue reading

alcidion

Alcidion to Present at TechKnow Invest Roadshow

6th October 2016, ASX Announcement Alcidion Group Limted (ASX: ALC) today announced that it will present at the TechKnow Invest Roadshow in Melbourne, Sydney and Brisbane from 18-21 October 2016. The TechKnow Invest Roadshow is an investor focused technology event, … Continue reading

analytica80x80

Analytica Share Placement of $250,000 to Cornerstone Investor

5th October 2016, ASX Announcement Analytica Ltd (ASX: ALT), manufacturer of the PeriCoach® System, is pleased to announce the allotment of 35,714,286 shares ($250,000) to cornerstone investor INOV8 LLC. The shares were issued at $0.007. An Allotment 3B is attached. … Continue reading

Proteo-logo-HR-80x80

SA Capital Initiates Proteomics Research Report

4th October 2016, ASX Announcement Proteomics International Laboratories Ltd (PILL, ASX: PIQ) is pleased to advise that SA Capital has initiated coverage on PILL. BUSINESS MODEL Proteomics International Laboratories Ltd (PILL) operates in three integrated areas unified by its proprietary … Continue reading

alcidion

Alcidion Medical 2016 Annual Report to Shareholders

30th September 2016, ASX Announcement Chairman’s Letter  Alcidion Group Limited (Alcidion or the Company) is pleased to present its Annual Report for the financial year ended 30 June 2016 (FY16 or Period). Alcidion is focused on anticipating the needs of … Continue reading

2-OPAL_Biosciences_Logo-psd (1)

Opal Biosciences Annual Report 2016

Hard-to-treat infections that used to be rare are now more common. Because of advances in medical management of cancers, HIV, cystic fibrosis and organ transplants, as examples, there is a larger pool of people with weakened immune systems or having … Continue reading

analytica80x80

Analytica Annual Report to Shareholders 2016

30th September 2016, ASX Announcement Principal activities of the Group during the yer were: The development of strategies on commercial sales of PeriCoach; The development of intellectual property of medical device and mobile health application in relation to patents and … Continue reading

medad

MedAdvisor features in CommSec Executive Series

21st September 2016, ASX Announcement MedAdvisor Limited (ASX: MDR, the Company) Australia’s leading digital medication adherence company are featured in CommSec’s Executive Series. Mr Robrt Read, CEO of MedAdvisor provides an update on the Company’s full year results, progress to … Continue reading

cellmid-2

Cellmid Ltd (ASX: CDY)

Cellmid is an Australian life sciences company with lead programs in multiple disease indications. Continue reading

medad

MedAdvisor Annual Report to Shareholders 2016

23rd September 2016, ASX Announcement Chairmans Letter In the rapidly expanding MedAdvisor world there has been little time for reflection,; nonetheless, we critically measure our performance, our wins, and our also-rans but we rarely muse on the past. Our Annual … Continue reading

alcidion

Alcidion Secures $525k Contract with The NT Health Department

22nd September 2016, ASX Announcement Highlights: $525k contract for Alice Springs and Royal Darwin Hospitals. Follows the recently awarded $1.7m for Miya Order Sets. Apple iPad’s view Electronic Patient Records and highlight emerging clinical risk. Optimises Patient Flow, Bed Management … Continue reading

Proteo-logo-HR-80x80

Proteomics International Receives FY16 R&D Tax Incentive

21st September 2016, ASX Announcement Innovative biomarker research conducted by Proteomics International Laboratories Ltd (PILL, ASX: PIQ) has been boosted by the receipt of more than half a million dollars in research and development tax incentive for the 2015-16 financial … Continue reading

biodiem 80x80

BioDiem Annual Report & Notice of Meeting 2016

NOTICE OF GENERAL MEETING  Notice is given that the Annual General Meeting of Members of BioDiem Limited (“BioDiem” or the “Company”) will be held at the offices of Grant Thornton, Wills Room, The Rialto, Level 30, 525 Collins Street, Melbourne … Continue reading

analytica80x80

Analytica’s Pericoach Published in Journal of Urology and Research

15th September 2016, ASX Announcement Analytica Ltd (ASX: ALT) continues to execute their strategy for demonstrating PerCoach® clinical efficacy with the company’s latest publication in the internationally regarded Journal of Urology and Research. The case study details the experience of … Continue reading

bps 80x80

BPS Completes Acquisition of Entertainment Publications

15th September 2016, ASX Announcement BPS Technology Limited “BPS” (ASX:BPS), is pleased to announce that the acquisition of the shares in Entertainment Publications of Australia (Pty) Ltd and Entertainment Publications Limited in New Zealand that was first announced on 12 … Continue reading

Caldera Logo

Caldera Says Third Study of PSA-Test Alternative Shows High Ability to Spot Prostate Cancer

15th September 2016, NBR By Jonathon Underhill Caldera Health, a New Zealand biotech company working on a gene-sequencing replacement for the world’s most widely used prostate cancer test, says its third clinical test has shown a strong ability to identify … Continue reading

medad

MedAdvisor Acquisition and Fund Raising Presentation

12th September 2016, ASX Announcement MedAdvisor Limited (ASX: MDR, the Company) today provides its acquisition and fund raising presentation following the announcement on the 31 August 2016 that it has entered into an agreement to acquire 100% of Health Enterprises … Continue reading

arthritis 75x55 (1)

Arthritis Relief Plus Selected by Australian Government for Entrepreneurial Program

12th September 2016, Chiropractic Economics Millions of Americans and others worldwide who suffer from joint pain including osteoarthritis will soon get access to a remarkable topical product developed with natural botanical extracts but supported by gold standard scientific research. The … Continue reading

4dx-80x80

4Dx Closes $500k Retail Funding Round to Add to $4M in Wholesale Capital

Innovative med-tech company 4Dx is a step closer to commercialising its four-dimensional lung imaging technology after successfully closing a $500,000 retail raise fully subscribed. This comes in addition to the company already raising AU$4m in capital from private investors which … Continue reading

alcidion

Alcidion to Host Product Overview Webinar

8th September 2016, ASX Announcement Alcision Product Overview Webinar, Wednesday, 14 September 2016 12.30pm AEST Sydney/Melbourne/Brisbane; 10.30am AWST Perth Time; 12.00pm ACST Adelaide/Darwin Time Alcidion Group Limited (ASX:ALC) today announced that it will hold an investor webinar on Wednesday, 14 … Continue reading

alcidion

Alcidion to Present at WA Broker Meets Biotech

8th September 2016, ASX Announcement Alcidion Group Limited (ASX:ALC) today announced that it will present at the AusBioTech WA Broker Meets Biotech Lunch on Thursday, 15 September 2016. Executive Director, Mr. Nathan Buzza will present to brokers, investors and financial … Continue reading

Proteo-logo-HR-80x80

Proteomics Investigates Biomarkers for Mesothelioma

6th September 2016, ASX Announcement PILL commences the search for protein biomarkers in the blood that could be used to diagnose mesothelioma. World Health Organisation estimates put the cost of treatment, compensation and settlement upwards of AU$667,00 for every sufferer.  Mesothelioma … Continue reading

4dx-80x80

4Dx 2016 Retail Investment Round Fully Subscribed

4Dx Limited is pleased to announce that our initial retail offering closed on the 31st August 2016, fully subscribed.  The company has been overwhelmed with the level of interest in our world-first technology and take this opportunity to thank everyone who … Continue reading

analytica80x80

Analytica Secures Share Placement of $250,000 to Cornerstone Investor

1st September 2016, ASX Announcement Analytica Ltd (ASX: ALT), manufacturer of the PeriCoach® System, is pleased to announce the allotment of 35,714,285 shares ($250,000) to cornerstone investor INOV8 LLC today. The shares were issued at $0.007. An appendix 3B is … Continue reading

medad2-80x80

Significantly Accelerating MedAdvisor’s Growth Through Acquisition of Healthnotes

31st August 2016, ASX Announcement Highlights MedAdvisot today announces the acquisition of Health Enterprises 2 Pty Ltd (“Healthnotes”), a leaser in healthcare technology for medication adherence management for a total consideration of $5.5 million, paid as 60% cash and 40% … Continue reading

Canndeo-logo-white-portrait1

Canndeo Ltd

Canndeo is an Australian based, internationally linked and vertically integrated medicinal cannabis company. Continue reading

Care-Guidance-Logo-2

Care Guidance Pty Ltd

Care Guidance is an early stage Australian company that matches and places people who need aged care with providers of aged care. Continue reading

analytica80x801

Analytica Announces 2016 Full Year Results; Total Revenue Up 89%; Granted US Patent for AutoStart Burette System in US

31st August 2016, ASX Announcement Analytica Ltd (ASX: ALT) “the Company” the manufacturer of the PeriCoach system, is pleased to announce its full year results for the financial year ended 30 June 2016. Operational Highlights FDA Over-the-counter (OTC) clearance for … Continue reading

alcidion5-80x80

Alcidion Group Limited Investor Update – August 2016

30th August 2016, ASX Announcement Shareholder Update Introduction to panellists. Alcidion Value Proposition. Achievements since listing. Strategic Direction. Investor Relations update. Commercialisation Strategy. North American Market Entry. Alcidion Overview Western Health Case Study Market Opportunity Global State of Health IT … Continue reading

alcidion

Alcidion to Host Investor Webinar on 31 August 2016

30th August 2016, ASX Announcement Alcidion investor webinar, Wednesday, 31 August 2016 10.30am Perth Times (AWST); 12.00pm Adelaide/Darwin Time (ACST); and 12.30pm Sydney/Melbourne/Brisbane (AEST) Alcidion Group Limited (Alcidion or the Company) (ASX:ALC) today announced that it will hold an investor … Continue reading

Proteo-logo-HR-80x80

Proteomics Annual Report to Shareholders 2016

26th August 2016, ASX Announcement Window On The Science – Proteins in medicine  A revolution in medicine is well underway, underpinned by the desire for a deeper understanding of the basis of disease beyond that of classical pathology. Determining what … Continue reading

QBiotics-logo-mono-blue-strapline-80x802

Watch the QBiotics Product Overview Video

ABOUT QBIOTICS QBiotics Limited is developing a pipeline of promising drugs in the area of cancer and wound healing. Its lead drug, EBC-46, targets solid tumours and is currently in late pre-clinical development in preparation for a Human Clinical Phase … Continue reading

medad2-80x80

MedAdvisor FY16 Preliminary Results – Growth in PEP Customers, Increase of 81% in Orders Received for PEP

26th August 2016, ASX Announcement Highlights Revenue from pharmacy subscriptions and patient engagement programs (PEP) has grown by ~24% to $1.43 million, driven primarily by pharmacy subscription growth Total revenue of $1.76m is 7% lower compared to FY15 which included … Continue reading

medad2-80x80

MedAdvisor Launching New Feature in Collaboration with Diabetes Australia

25th August 2016, ASX Announcement Melbourne, 25 August 2016: MedAdvisor Limited (ASX:MDR) Australia’s leading digital medication adherence company, in collaboration with the national diabetes organisation Diabetes Australia, today launches a new tool that allows people living with diabetes to order … Continue reading

Proteo-logo-HR-80x80

Proteomics International Expands Diagnostics Portfolio to Endometriosis

24th August 2016, ASX Announcement Life sciences company Proteomics International Laboratories Ltd (PILL, ASX: PIQ) is applying its disruptive proteomics technology platform to new areas of significant unmet medical need. PILL is investigating protein ‘fingerprints’ that can diagnose endometriosis from … Continue reading

QBiotics-logo-mono-blue-strapline-80x80

QBiotics Share Offer Update: View Investor Presentation Online; Share Offer Progress; Seven News Story; Frequently Asked Questions Answered

QBIOTICS SHARE OFFER UPDATE The QBiotics Share Offer has now been open for 1 week. Below is an update on how it is progressing, as well as links to further useful information and FAQs about the Offer. UPDATE ON SHARE … Continue reading

QBiotics-logo-mono-blue-strapline-80x80

Anti-Cancer Drug Discovered in Rainforest Successfully Tested on Humans

22nd August 2016, The Cairns Post by Daniel Bateman A POTENTIAL cancer cure discovered in Far North Queensland that has been successfully tested on human patients is hoped to become commercially available in four years. Brisbane-based researchers QBiotics have released … Continue reading

Proteo-logo-HR-80x80

Proteomics Secures First Commercialisation Deal for PromarkerD

18th August 2016, ASX Announcement Life sciences company Proteomics International Laboratories  (ASX: PIQ) (PILL) has signed an exclusive license for its PromarkerD assay for the diagnosis of diabetic kidney disease in the Dominican Republic in Central America. Highlights: Diabetic kidney … Continue reading

QBiotics-logo-mono-blue-strapline

QBiotics Channel 7 News Feature: Scientists Find Australian Berry to Cure Cancer

15th August 2016, 7 News A berry found on Australia’s Blushwood tree in the far north is believed to cure many types of cancer. Scientists made the breakthrough with EBC46 making tumours disappear in just 48 hours. ABOUT QBIOTICS LIMITED … Continue reading

QBiotics-logo-mono-blue-strapline

QBiotics Share Offer is Now Open

We are pleased to inform you that the QBiotics Share Offer is now Open. The Offer Site on the QBiotics website is now open where you can: Download the replacement Prospectus Apply for shares via the online application process Go … Continue reading

medad

MedAdvisor Signs MoU with Glaucoma Australia Partnership to Assist 300,000 Australians

15th August 2016, ASX Announcement Highlights MedAdvisor has signed a Memorandum of Understanding with Glaucoma Australia, the leading not-for-profit patient support organisation for people living with glaucoma Glaucoma Australia will become a MedAdvisor Health Association Partner and promote the MedAdvisor … Continue reading

4dx-80x80

Revolutionary 4Dx Locks Major Deal with Top US Hospital

11th August 2016, Australian Anthill Bu Gerald Ainomugisha Australian medtech start-up, 4Dx is a step closer to the integration of its visionary and breakthrough technology into everyday healthcare through its latest hardware sale to leading U.S. hospital, Cedars-Sinai Medical Center, … Continue reading

atomo 800x800

Bill Gates Backs Aussie Biotech Start-Up Atomo Diagnostics

11th August 2016, Sydney Morning Herald By Brian Robins In a rare public display of support for Australian technology, a large US investment fund backed by Microsoft founder Bill Gates has taken a stake in a local biotech start-up. Launched in 2010 and … Continue reading

biodiem 80x80

BioDiem Complete Successful Entitlement Offer

9th August 2016, BioDiem BioDiem advises that it has now successfully completed the issue and allotment of entitlement and shortfall convertible preference shares under the shortfall facility of its recent Non-Renounceable pro-rata Entitlement Offer. Funds will be used to progress the … Continue reading

analytica80x80

PeriCoach Granted Patent Protection in China

3rd August 2016, ASX Announcement Analytica Ltd (ASX: ATL), manufacturer of the PeriCoach® System has been granted patent protection (Patent No ZL201280018210.2) in the People’s Republic of China for the device’s unique pelvic floor sensing technology. It is estimated that … Continue reading

alcidion

Alcidion to Meet with NSW Health Minister

2nd August 2016, ASX Announcement New South wales Governemnt Policy requires certain details of meetings held with the Minister to be publicly disclosed ona quarterly basis. The policy (Publication of Ministerial Diaries) is available at www.dpc.nsw.gov.au In accordance with the … Continue reading

alcidion

Alcidion Group Quarterly Report: Successful Reverse Takeover of Naracoota Resources, Commercialiation Strategy Commenced

29th July 2016, ASX Announcement Executive Summary Alcidion’s first quarter following the successful reverse takeover of Naracoota Resources Limited marked the commencement of the Company’s commercialisation strategy of its Miya platform. As at 29th July 2016 the Company maintains $6.51 … Continue reading

alcidion

Alcidion FY16 Update: Public Listing, $2.35m MoU with Western Health, $2.20m to Research & Development

Alcidion Group Limited (ASX: ALC), an innovative health informatics company, has had an exciting past 12 months following its public listing on 29th February 2016. The healthcare industry has realized that the traditional approaches to patient flow are inadequate to … Continue reading

alcidion

Alcidion (ASX:ALC) Sign $2.35m MoU with Western Health

Executive Summary: $2.35m MoU for Footscray, Williamstown & Sunshine Hospitals. Initial Term of three years, with an option to extend for an additional two years. Apple iPad’s view Electronic Patient Records and highlight emerging clinical risk. Optimises Patient Flow, Bed … Continue reading

medikane 80x80

Medikane FY16 Update: $500,000 Raised, Share Price Increased 22%, Appointing Distributors in India, Thailand, Sri Lanka, and Oman

MediKane raised $500,000 recently which increased the share price by 22%. Ex Hardie Exec VP Peter Baker joined the Board and Michael Goldman ex Diabetes Australia joined as Senior VP USA posted in New York. The business is appointing distributors in … Continue reading

medad

MedAdvisor Quarterly Report June 2016: Strong Operational Performance, Cash Receipts Totals $292k, Pharmacy Network and Number of Patients Increases

29th July 2016, ASX Announcement Highlights Strong operational performance with an increase across all key revenue drivers – Over 180,000 patients using the platform as at 30 June 2016, a 132% increase on the prior corresponding period –  Expansion of … Continue reading

analytica80x80

Analytica’s PeriCoach Sexual Health Indication Clarification from USFDA

29th July 2016, ASX Announcement Analytica Ltd (ASX: ALT), manufacturer of the PeriCoach® system, is pleased to announce that it has received clarification from the US Food and Drug Administration regarding additional marketing claims for improved sexual function in women … Continue reading

analytica80x80

Analytica Quarterly Report: Cash Outflow Reduced by $824k, INOV8 Additional $500k Placement, FDA Clearance

Highlights: Cash outflow reduced by $824k on previous quarter INOV8 additional $500k placement FDA Over-the-Counter clearance for PeriCoach AutoStart Burette granted US patent Analytica Ltd (ASX: ALT), manufacturer of the PeriCoach® System, is pleased to announce its Appendix 4C – … Continue reading

Proteo-logo-HR-80x80

Proteomics International Quarterly Report June 2016: Cash Flow Strengthened & Cash Burn Reduced

28th June 2016, ASX Announcement Life sciences comp-any Proteomics International Laboratories Ltd (ASX: PIQ) )the Company, PILL), is pleased to provide the following update on its business activities for the three month period to 30 June 2016. Building on previous … Continue reading

alcidion

Alcidion Appoint Resapp Health Co-Founder Brian Leedman

28th July 2016, ASX Announcement Alcidion Group Limited (ASX: ALC), a global leader in Clinical Informatics, today announced the appointment of Mr. Brian Leedman to the bord of the Company. This move comes at a pivotal time for Alcidion as … Continue reading

biodiem 80x80

BioDiem FY16 Update: Nasovac-S Export Approved, Clinical Trials Due to Finish FY17, New Formulations Planned

BioDiem’s focus is the prevention and treatment of infectious diseases. Royalties flow to BioDiem from sales of Nasovac-S™ in India, a flu vaccine manufactured by Serum Institute of India (SII) under licence from BioDiem. In FY16, after achieving approval to … Continue reading

biodiem 80x80

BioDiem Entitlement Offer Closes Friday July 29th

BioDiem’s pro rata nonrenounceable Entitlement Offer to raise up to $1,250,000 (before costs) is closing soon. Funds will be used to progress the next phase of commercialization of BioDiem’s influenza vaccine (LAIV) licensing business; and its antimicrobial, BDM-I, in development for … Continue reading

analytica80x80

Analytica Share Placement of $500k to Cornerstone Investor

27th July 2016, ASX Announcement Analytica Ltd (ASX: ALT), manufacturer of the PeriCoach®  System, is pleased to announce the further placement of new fully paid ordinary share to our American Virgin Island cornerstone investor INOV8 LLC. Shares will be issued … Continue reading

alcidion

Executive Director of Alcidion to Present at BioShares Biotech Summit

26th July 2016, ASX Announcement  Alcidion Group Limited (ASX: ALC) is pleased to announce that Executive Director, Mr Nathan Buzza, will present a paper on “Opportunities for Investment in Digital Health” at the Bioshares Biotech Summit on July 29th 2016 … Continue reading

alcidion

Alcidion’s Professor Malcolm Pradhan Presents at Health Informatics

26th July 2016, ASX Announcement Overview Why are smart machines are important for health care The emergence of deep learning Deep learning vs existing methods Some early results Practical tips on getting started Future directions Health informatics company with products … Continue reading

biodiem 80x80

BioDiem Non-Renounceable Pro-rata Entitlement Offer Closes July 29th

15th July 2016 BioDiem’s pro rata nonrenounceable Entitlement Offer to raise up to $1,250,000 (before costs) is closing soon. Funds will be used to progress the next phase of commercialization of BioDiem’s influenza vaccine (LAIV) licensing business; and its antimicrobial, BDM-I, … Continue reading

4dx-80x80

Video: 4Dx Investor Presentation June 2016

Please watch 4Dx’s Executive Chairman, Dr Andreas Fouras, talk in further detail about the company and investment offer at the recent Sydney Investor Evening June 2016. ABOUT 4DX 4Dx brings a technological solution set to disrupt this multi-billion dollar sector through … Continue reading

analytica80x80

Analytica’s AutoStart Burette Granted US Patent

15th July 2016, ASX Announcement Analytica (ASX:ALT) is pleased to announce that the AutoStart® burette system has been granted patent protection by the US Patent and Trademarks Office. US Patent 9352080 has a priority date of 13 October 2005 and … Continue reading

QBiotics-logo-mono-blue-strapline

QBiotics FY16 Update: $16m Raised, New Appointments to Board, Preparation for Further Registrations

The last 12 months has seen QBiotics strengthen both its board and balance sheet. Over the last 12 months, the company has raised $16m and will soon raise a further $10m, giving them a balance sheet of approx $30m. These … Continue reading

analytica80x80

Analytica Receive FDA Approval for Over the Counter Clearance PeriCoach

12th July 2016, ASX Announcement Analytica Ltd (ASX: ALT) is pleased to announce that the US Food and Drug Administration (FDA) has granted the company over-the-counter (OTC) clearance for the PeriCoach system, previously available in the US by prescription only. … Continue reading

cellmid-2

Cellmid FY16 Update: Strong Revenue Growth, Full Range Launched, Presence Built in Major Markets

Cellmid, a life sciences accelerator, continued to build its consumer health business during FY2016 and is on track to deliver strong revenue growth for the period. The Company launched its full range of clinically validated hair growth products, evolis®, in … Continue reading

met-80x80

Métier Medical FY16 Update: Bronze Awarded in Major International Awards, $1.3 Million Raised, New CEO

Métier Medical Limited wins Bronze in a major international design awards competition and Raises $1.3 Million in the 6 months between January & June 2016. Métier Medical has seen its safety hypodermic needle with unique secure-lok mechanism win Bronze in … Continue reading

4dx-80x80

4Dx FY16 Update: Share Price Increase to $312.50, Series A Wholesale Capital Raise, Signed Commercial Collaboration Agreements with Three Major US Hospitals

4Dx Ltd is an early stage medical technology company based in Melbourne, Australia, established to commercialise four-dimensional lung imaging technology: 4DxV. The Company had a hugely successful FY15/16 with Share price increasing to $312.50 (from $270 and $100 over the … Continue reading

analytica80x80

Analytica FY16 Update; Successful $2.4m Capital Raise, R&D on PeriCoach® System, International Case Studies Published

Analytica has had a productive 2016, including a successful $2.4m capital raise with a cornerstone investment from Innov8 LLC, and the appointment of Dr. Thomas Lönngren to the Board. The company is driving R&D work on the PeriCoach® System, aiming … Continue reading

alcidion

Alcidion’s CMO to Present at Health Informatics Conference

1st July 2016, ASX Announcement Highlights: Professor Malcolm Pradhan to present at Health Informatics Conference. Alcidion to unveil “Deep Learning” Product Roadmap Strategy for Patient Flow. Technology incorporates predictive analytics to streamline Patient Flow. Alcidion Group Limited (ASX:ALC) is pleased … Continue reading

medad

Major Biopharmaceutical Signs to Up to MedAdvisor Patient Engagement Program

1st July 2016, ASX Announcement Highlights: MedAdvisor is collaborating with Bristol-Myers Squibb Australia (BMS) to deliver a patient engagement and education program concerning one of its products Commencing shortly the 12-month patient engagement program (PEP) is being delivered via MedAdvisor’s … Continue reading

medad

MedAdvisor Sees Strong Growth in Key Business Drivers

29th June 2016, ASX Announcement Highlights Strong progress across key revenue drivers for the business: -Rapid acceleration in patient user growth, with approximately 18,000 patients now using  the platform, a monthly growth rate of ~10% (vs. 6% in March Qtr.) … Continue reading

Proteo-logo-HR-80x80

Proteomics International Laboratories Board Changes

28th June 2016, ASX Announcement Proteomics International Laboratories Ltd (ASX: PIQ) (the Company) announces that Dr Bill Parker and Mr James Moses have resigned as Directors of the Company. Dr Parker was a founder of Proteomics International in 2001, and … Continue reading

alcidion

Tasmania’s Northern Integrated Care Service Goes Live with Alcidion

27th June 2016, ASX Announcement Highlights: Tasmania’s Department of Health & Human Services goes live with Miya Clinic. Provides a unified Electronic Medical Records for Outpatient Clinics. Future potential integration into the National Personally Controlled Electronic Health Record (PC-EHR). Alcidion … Continue reading

vixtel-unity-logo

Vixtel Unity

Vixtel saw a need to reduce the number of devices currently used by business, namely desktop PC, laptop, desktop phone and tablet. Continue reading

medad

GlaxoSmithKline Extends Service Agreement with MedAdvisor

16th June 2016, ASX Announcement Highlights GlaxoSmithKline (GSK) Australia extends its services agreement with MedAdvisor for a further 12 months. GSK will continue utilising MedAdvisor’s medication management platform to provide relevant information for patients prescribed three medicines within GSK Australia’s … Continue reading

biodiem 80x80

BioDiem Non-Renounceable Pro-Rata Entitlement Offer

14th June 2016, BioDiem BioDiem announces a pro rata nonrenounceable Entitlement Offer to raise up to approximately $1,250,000 (before costs). Funds will be used to progress the next phase of commercialization of BioDiem’s influenza vaccine (LAIV) licensing business; and its … Continue reading

alcidion

Alcidion Develops Data Acquisition Technology for NEDA

15th June 2016, ASX Announcement Highlights: Data Acquisition Technology developed for National Echo Database Australia. Collates several million echocardiograms into national database. Alcidion Group Limited (ASX: ALC) has developed a new technology in partnership with the National Echocardiography Database of … Continue reading

Proteo-logo-HR-80x80

Proteomics PromarkerD Development Advances in China

14th June 2016, ASX Announcement Highlights: PILL and its Chinese partner Newsummit Biopharma have secured funding towards development for an In vitro Diagnostic (IVD) kit for PromarkerD in China. Chinese patent granted for PromarkerD as a predictive and diagnostic test … Continue reading

alcidion

Alcidion’s Intelligent Cardiovascular Information System (iCVIS) to be Delivered to Sunshine Coast University Hospital Through FUJIFILM

3rd June 2016, ASX Announcement Highlights:  Strengthening of the commercialisation of iCVIS through FUJIFILM. Contract to deliver iCVIS to Sunshine Cost University Hospital. Cardiovascular Information System market estimated to be $USD917m by 2020. FUJIFILM Medical Systems, a division of FUJIFILM … Continue reading

analytica80x80

Analyticas’ AutoStart Burette Listed Through Queensland Health Tender

3rd June 2016, ASX Announcement Analytica (ASX: ALT) is pleased to announce that the AutoStart® infusion system product has been listed on the Queensland Health purchasing schedule. The product was listed by Medical Australia Ltd (ASX: MLA) the Australian sponsor … Continue reading

QBiotics-logo-mono-blue-strapline

QBiotics Presents its Veterinary Cancer Compound

1st June 2016, Life Scientist Australian life sciences company QBiotics outlined the latest clinical developments in its cancer compound, EBC-46, to an audience of veterinary cancer experts last week. Speaking at The World Veterinary Cancer Congress in Brazil, QBiotics CEO Dr Victoria Gordon and … Continue reading

medad

MedAdvisor Signs Strategic Agreement with Arrow Pharmaceuticals

1st June 2016, ASX Announcement Highlights: MedAdvisor has  sign a strategic agreement with Arrow Pharmaceuticals, one of Australia’s largest generic pharmaceutical manufacturers Arrows Pharmaceuticals’ 35 plus strong national sales teams to promote the MedAdvisor platform to its extensive first-line customer … Continue reading

atomo 800x800

John Kelly, Atomo Diagnostics’ Founder and CEO Interviewed on Switzer TV

25th May 2016, Swtizter Atomo Diagnostics is making waves in the diagnostics technology space, and has even attracted the support of the Bill and Melinda Gates Foundation. To look at the company’s innovations, CEO John Kelly joins the show (broadcast … Continue reading

atomo 800x800

Innovative New Rapid Blood Test to Tackle Tropical Diseases from Atomo Diagnostics

30th May 2016, Atomo Diagnostics Award-winning designer and manufacturer of diagnostic medical devices, Atomo Diagnostics today announced that it has been successful in securing $1.38 million in grant funding from the Australian Government to assist in the development and commercialisation … Continue reading

medad

MedAdvisor Signs Agreement with Novartis Pharmaceuticals to Deliver Patient Engagement & Education Program

30th May 2016, ASX Announcement Highlights: MedAdvisor signs a 12 month agreement with Novartis Pharmaceuticals Australia to deliver patient engagement and education program via the MedAdvisor platform Program will provide educational resources for patients, helping ensure they take their medications … Continue reading

atomo 800x800

Gates Foundation’s Global Health Chief Joins Atomo Diagnostics

28th May 2016, The Australian By Sarah-Jane Tasker The top lieutenant at the Bill & Melinda Gates Foundation’s ­global health fund is joining the board of Australia’s Atomo Diagnostics after the fund took an ­equity position in the medical ­device … Continue reading

Proteo-logo-HR-80x80

Proteomics Gaining Strong Traction in Analytical Services

20th May 2016, ASX Announcement PILL has generated monthly revenues of $100,000 in each of March and April (a 60% uplift on the previous monthly average). Several recent contract wins underscore ongoing activity. Growth driven by biosimilars (generic protein drug) … Continue reading

analytica80x80

Case Studies of Analytica’s PeriCoach Published in Peer Reviewed Urology Journal

19th May 2016, ASX Announcement Analytica Ltd (ASX: ALT) manufacturer of the PeriCoach® System is pleased announce the publication of case studies describing pelvic floor training with Pericoach in the Urologic Nursing Journal of the US Society of Urologic Nurses … Continue reading

Arthritis-Plus-Logo3

Arthritis Relief Plus Ltd

ARP has developed and patented a novel technology – Acteev® with its lead product – 4Jointz®, a topical botanical cream addressing a significant unmet market need. It is commercial ready for key international markets. Continue reading

4dx 80x80

4Dx Presents at AusBio in Hong Kong and Singapore

4Dx will take part in the spotlight presentations to international investors as part of the AusBiotech Global Investment Event Series, with events taking place in Asia, the US and Australia. Through a professional business-matching program 4Dx will connect with life … Continue reading

PILL logo HR

Proteomics March Update: PromarkerD Progress, Indian Biotech Market Expansion & Solid Quarter Results

26th April 2016, ASX Announcement Life sciences company Proteomics International Laboratories Ltd (ASX:PIQ) (the Company, PILL)  is pleased to provide the following update on its business activities for the three month period to 31 March 2016. Highlights  PromarkerD progress: 500 … Continue reading

Alcidion-Logo-Duotone

Alcidion Group Ltd (ASX: ALC)

Alcidion Corporation is an ASX-listed leading health informatics company founded by the former CEO of the SA Heath Department and Professor Malcolm Pradhan. Continue reading

Author-it-Logo3

Author-IT

Author-it is a fast growing SaaS business that provides cloud based, authoring and content management solutions, purpose-built for the life sciences industry where documentation accounts for ~25% of the average cost of bringing a drug to market. Continue reading

analytica80x80

Analytica Share Purchase Plan Results; Approximately $2.4m Raised

20th April 2016, Analytica Medical Analytica Ltd (ASX: ALT), The Company is pleased to announce that the Share Purchase Plan was well supported by shareholders with $567,700 being received. 222,627,485 shares at $0.00255 will be allotted today. Following allotment of … Continue reading

wilog

Singaporean Venture Capital Fund Seeks Tech, Fintech and MedTech Opportunities

A venture capital fund backed by the Singapore Government and with over $250M of AUM, is looking for investment opportunities from Australia and New Zealand. The fund invests in startups from all over the world and at various stages of a startup’s … Continue reading

medikane 80x80

MediKane: Two Products, Two Global Markets

Why you should invest in our growing business  GLOBAL DEMAND: MediKane sells a proven natural product that addresses the growing global problem of diabetes. We also sell a related product that helps solve one of healthcare’s most intractable problems – … Continue reading

QBiotics-logo-mono-blue-strapline

Cochlear Chairman, Rick Holliday-Smith, to Head QBiotics Board

Australian life sciences company QBiotics Limited today announced the appointment of Rick Holliday-Smith as its new Non-Executive Chairman. In accepting the appointment Mr. Holliday-Smith said: “I have been a QBiotics shareholder for some time and have watched the technology develop … Continue reading

Caldera Logo

Caldera Health Appoints Robert Mitchell to CEO Role

14th April 2016 Caldera Health has appointed Rob Mitchell to the role of Chief Executive Officer to manage overall operations of the Company and to drive commercialisation of its gene-based prostate cancer diagnostic tests. New Zealand-born, Rob is a highly … Continue reading

PILL logo HR

Proteomics to Expand Operations in Indian Market

14th April 2016, ASX Announcement Highlights: PILL to expand to Indian biotech sector – rapidly growing global biotech hub forecast to be worth $US100b by 2025. PILL to conduct India trade visit this month to drive uptake to biosimilars analytics … Continue reading

4dx 80x80

4Dx AFR Feature: Tel Aviv Uni President Tells Aussie Unis to Do More to Support Innovation

11th April 2016, AFR By Yolanda Redrup The president of Israel’s Tel Aviv University, Professor Joseph Klafter, says Australian universities need to find corporate partners to sponsor the development of early stage ideas, which have commercial potential. Australian universities have historically struggled with … Continue reading

analytica80x80

Analytica Investor Update Webcast: Link to Recording

 8th April 2016 Analytica Ltd (ASX:ALT) has released a recording of the investor webinar held on Thursday 7th April at 9am AEST to discuss the company’s future strategy and planning for the year ahead. During the webinar, Analytica CEO Geoff Daly, VP … Continue reading

analytica80x80

Analytica Invites Investors to Webcast

5th April 2016, Analytica Analytica Ltd (ASX: ALT), invites investors to webcast hosted by Geoff Daly, CEO of Analytica Limited. The webcast will be held on Thursday 7th April at 9am AEST. Following a live presentation, including pre-submitted questions, there will … Continue reading

4dx 80x80

4Dx Featured on Start Up Smart and SBS Radio

Andreas Fouras, Founder and Executive Chairman of 4Dx talks to Start Up Smart and SBS Radio about his vision of making a life-changing contribution to global healthcare, and his confidence in this opportunity to build a multi-billion dollar business. To read “All in”: What … Continue reading

biodiem 80x80

BioDiem Commence Influenza Vaccine Clinical Trial in China

31st March 2016, BioDiem Changchun BCHT Biotechnology Co (BCHT) has made rapid progress in the development of its ‘flu vaccine in China since licensing the LAIV technology from BioDiem just three years ago. During this time, BCHT has developed the manufacturing … Continue reading

alcidion

Alcidion Set to Trial Miya Patient Flow

16th March 2016, LinkedIn Alcidion Group Limited (ASX:ALC), a leading health informatics company has secured an Implementation Planning Study for a large hospital, which is part of a leading Australian Private Hospital group, to deploy its Electronic Bed Management (EBM) Solution … Continue reading

PILL logo HR

Proteomics Commences Therapeutic Drug Discovery Program

23rd Marc h 2016, ASX Announcement Highlights:  PILL to utilise its proprietary disruptive technology platform to assess potential new painkilling and antibiotic drug compounds. Therapeutic Drug Discovery is one of PILL’s core business areas and is a major growth market … Continue reading